Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy-Reference-Cited by-同舟云学术

Trajectories of fear of progression in nasopharyngeal carcinoma patients receiving proton and heavy ion therapy

Published:2023-10-16 Issue:11 Volume:31 Page:
ISSN:0941-4355
Container-title:Supportive Care in Cancer
language:en
Short-container-title:Support Care Cancer

Author:

Zheng Mimi,Wang Shuman,Zhu Yu,Wan Hongwei

Funder

Pudong New Area Science and Technology Development Fund

Shanghai Pudong New Area Health Commission

Fudan University-Fuxing Nursing Research Fund

Publisher

Springer Science and Business Media LLC

Subject

Oncology

Link

https://link.springer.com/content/pdf/10.1007/s00520-023-08085-8.pdf

Reference44 articles.

1. Bray F, Ferlay J et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA A Cancer J Clin 68(6):394–424

2. Sung H, Ferlay J, Siegel RL et al (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA Cancer J Clin 71(3):209–249

3. Bray F, Ferlay J, Soerjomataram I et al (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424

4. Lv Y, Lin A (2021) Review of the risk factors for nasopharyngeal carcinoma. Chin J Hosp Stat 28(02):188–192 (in Chinese)

5. Pan Y (2020) Clinical observation of apatinib combined with GP regimen in the treatment of recurrent or metastatic nasopharyngeal carcinoma (in Chinese)

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Latent profiles of resilience and associations with quality of life in head and neck cancer patients undergoing proton and heavy ion therapy;Frontiers in Oncology;2024-01-17